MedTrace Logo

Ablative Therapy in the Management of Prostate Cancer

NCT03492424 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-12-23

No results posted yet for this study

Summary

The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.

Conditions

Interventions

DEVICE

cryotherapy

Subjects will receive focal cryotherapy for treatment of prostate cancer

Sponsors & Collaborators

  • Prostate Cancer Foundation

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Tim McClure, M.D. · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2032-03-02
Completion
2039-09-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03492424 on ClinicalTrials.gov